Quantcast

Latest B-cell activating factor Stories

2014-03-31 16:27:30

HAYWARD, Calif., March 31, 2014 /PRNewswire/ -- Anthera Pharmaceuticals, Inc. (Nasdaq: ANTH), a biopharmaceutical company focused on developing and commercializing products to treat autoimmune diseases, today announced the appointment of Steven Engle to and the departure of Dr. James Healy, MD, PhD from its Board of Directors. "Steve's extensive experience in late-stage clinical development will be an invaluable resource to the Company," said Dr. Christopher S. Henney, Chairman of...

2014-01-30 16:26:47

HAYWARD, Calif., Jan. 30, 2014 /PRNewswire/ -- Anthera Pharmaceuticals, Inc. (NASDAQ:ANTH), a biopharmaceutical company focused on developing and commercializing products to treat autoimmune diseases, announced today that Paul F. Truex, President and Chief Executive Officer, will present a corporate update on the progress of the Company's development programs including additional plans for blisibimod beyond autoimmune disorders at three conferences in February and early March. Investor...


Word of the Day
bibliopole
  • A bookseller; now, especially, a dealer in rare and curious books.
This word comes from a Greek phrase meaning 'book seller.'
Related